Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

The pharmaceutical CDMO industry: Number of deals per country

The contract manufacturing market reports highest M&A activities in USA, India, China and Germany. Find out more in our report: https://go.ey.com/2AIlfBr

  • Login to see the comments

  • Be the first to like this

The pharmaceutical CDMO industry: Number of deals per country

  1. 1. The contract manufacturing market shows highest M&A activity in USA, India, China and Germany EY CDMO Study The US clearly leads the CDMO M&A table by number of deals and deal value, closely followed by China, India and Germany. There is a clear divide who invests in CDMO assets: while most of the deals in Asia take place within national borders, the US and European countries – in particular Germany – attract significant interest from international investors. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 14 Germany 19 United Kingdom 22 France 23 China 31 India 31 US 134 Switzerland 7 Ireland 8 Belgium 9 Japan 10 Sweden 11 Australia 11 Italy 11 Spain 14 Canada Cross-border Internal Number of deals M&A target HQRank Number of deals per country EV (US$b) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Cross-border Internal Norway 0.9 Switzerland 1.0 France 1.0 United Kingdom 1.1 Italy 2.0 Canada 2.4 Japan 2.5 Germany 2.8 India 3.5 China 7.1 US 21.1 Poland 0.7 0.9 Denmark 0.6 Spain 0.6 Turkey M&A target HQRank Sum of EVs per country

×